Deree-The American College of Greece | Greece
AUTHOR PROFILE
Scopus
Orcid ID
Google Scholar
EARLY ACADEMIC PURSUITS
Spyridon Theofilopoulos embarked on his academic journey with a Bachelor of Science degree in Biochemistry from Imperial College of Science, Technology and Medicine, London, U.K. Following this, he pursued his passion for developmental neurobiology, obtaining his Ph.D. from the same institution. His doctoral research, supervised by Professor Henry F. Bradford, focused on neurotrophic factors in neurotransmitter phenotype determination and neuroprotection in the developing human and rat brain.
PROFESSIONAL ENDEAVORS
Dr. Theofilopoulos has held various academic positions internationally, demonstrating his expertise and commitment to the field. Noteworthy roles include his tenure as a Forskare (Senior Researcher/Assistant Professor) at the Karolinska Institute, Stockholm, Sweden, and as a Sêr Cymru II Rising Star fellow and Associate Professor at Swansea University Medical School, Swansea, U.K. Currently, he serves as a Professor and Instructor at the Biomedical Sciences Department of Deree-The American College of Greece, Athens, Greece.
Dr. Theofilopoulos has made significant contributions to the field of developmental neurobiology, particularly in the areas of neuroprotection and neurotransmitter phenotype determination. His collaborative research with Teva Pharmaceuticals during his Ph.D. led to the development of Rasagiline, a novel compound for the treatment of Parkinson’s disease. Moreover, his work at Swansea University resulted in the establishment of the spin-off company CholesteniX Ltd, aiming to develop specific cholesterol metabolites for Amyotrophic Lateral Sclerosis therapy.
IMPACT AND INFLUENCE
Theofilopoulos's research has not only contributed to scientific advancements but has also garnered recognition and accolades. He has been invited as a speaker to numerous conferences and meetings, highlighting the impact of his work in the scientific community. Furthermore, his efforts were acknowledged with awards such as the "Outstanding Research and Innovation collaboration in Medicine, Health and Life Sciences" award in 2022.
ACADEMIC CITATIONS
Dr. Theofilopoulos's work has been cited extensively, indicating its relevance and impact in the scientific community. His publications have appeared in reputable journals, and he has served as a reviewer for various scientific publications, including Scientific Reports, eLife, and Frontiers in Cell and Developmental Biology.
LEGACY AND FUTURE CONTRIBUTIONS
Dr. Theofilopoulos's legacy lies in his dedication to advancing knowledge in developmental neurobiology and his commitment to mentoring the next generation of scientists. His research funding awards underscore the importance of his work and pave the way for future discoveries in the field. As he continues his academic journey, his contributions are expected to further shape the landscape of neuroscience research.
NOTABLE PUBLICATIONS